Recurrence of Disease Following Liver Transplantation: Nonalcoholic Steatohepatitis vs Hepatitis C Virus Infection

Recurrence of Disease Following Liver Transplantation: Nonalcoholic Steatohepatitis vs Hepatitis C Virus Infection

AbstractBackground: Nonalcoholic steatohepatitis (NASH) is an increasing indication for orthotopic liver transplantation (OLT) in the United States and other countries. However, the incidence of disease recurrence and natural course following OLT remains incompletely understood.Objective: To estimat...

Full description

Bibliographic Details
Main Authors:	A Hanouneh, C Macaron, R Lopez, AE Feldstein, L Yerian, B Eghtesad, NN Zein
Format:	Article
Language:	English
Published:	Shiraz University of Medical Sciences 2011-04-01
Series:	International Journal of Organ Transplantation Medicine
Subjects:	Nonalcoholic steatohepatitis Hepatitis C virus Orthotopic liver transplantation Prognosis
Online Access:	http://home.sums.ac.ir/~habibzaf/ojs/index.php/IJOTM/article/view/67/125

Similar Items

Angiogenesis in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study)
by: Gavrilyuk O.M.
Published: (2013-12-01)

Challenges and opportunities in nonalcoholic steatohepatitis
by: Wang Xiaobo
Published: (2022-08-01)

Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
by: Mindy C.W. Lam, et al.
Published: (2012-07-01)

Histological Remission during Corticosteroid Therapy of Overlapping Nonalcoholic Steatohepatitis and Autoimmune Hepatitis: Case Report and Literature Review
by: Shinichiroh Fukuda, et al.
Published: (2011-09-01)

Disease Progression in a Patient with Nonalcoholic Steatohepatitis
by: Ping-Huei Tseng, et al.
Published: (2008-10-01)

Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology
by: In Cheol Yoon, et al.
Published: (2019-05-01)

Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
by: Seonghwan Hwang, et al.
Published: (2021-10-01)

Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis
by: S.M. Touhidul Islam, et al.
Published: (2020-09-01)

Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis
by: D.N. Amarapurkar, et al.
Published: (2006-01-01)

Taurine and tea polyphenols combination ameliorate nonalcoholic steatohepatitis in rats
by: Wenhua Zhu, et al.
Published: (2017-09-01)

Possible Development of Burn-Out Nonalcoholic Steatohepatitis under Long-Term Steroid Use
by: Soichiro Ota, et al.
Published: (2022-09-01)

Nonalcoholic steatohepatitis: global impact and clinical consequences
by: Khaled Kabarra, et al.
Published: (2021-10-01)

Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
by: Mazen Noureddin, et al.
Published: (2020-10-01)

Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism
by: Beatriz Villar, et al.
Published: (2021-06-01)

Differences In Hepatic Expression of Iron, Inflammation and Stress-Related Genes in Patients with Nonalcoholic Steatohepatitis
by: Priya Handa, et al.
Published: (2017-01-01)

Hepatitis C and Nonalcoholic Steatohepatitis in the 21st Century: Impact on Liver Disease and Liver Transplantation
by: Sonia Samuel, et al.
Published: (2023-06-01)

Mineral Water Tib-2 in Treatment of Patients with Nonalcoholic Steatohepatitis
by: N. V. Efimenko, et al.
Published: (2012-09-01)

Integrated Multichip Analysis Identifies Potential Key Genes in the Pathogenesis of Nonalcoholic Steatohepatitis
by: Jianzhong Ye, et al.
Published: (2020-11-01)

Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
by: Bing Yang, et al.
Published: (2022-09-01)

Nonalcoholic steatohepatitis and biliary sludge in people with metabolic syndrome
by: V G Radchenko, et al.
Published: (2016-09-01)

Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients
by: Haghpanah Babak, et al.
Published: (2003-10-01)

The polarizable and reprogrammable identity of Kupffer cells in Nonalcoholic Steatohepatitis
by: Zahr Tarik, et al.
Published: (2022-08-01)

Key hepatic signatures of human and mouse nonalcoholic steatohepatitis: A transcriptome–proteome data meta-analysis
by: Jeong Joo Pyo, et al.
Published: (2022-10-01)

Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
by: Bing Yang, et al.
Published: (2023-09-01)

Angiogenic effects of leptin in patients with nonalcoholic steatohepatitis
by: Gaafar Nagah, et al.
Published: (2005-01-01)

Caspase-11–Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic SteatohepatitisSummary
by: Yingwei Zhu, et al.
Published: (2021-01-01)

A simple method for inducing nonalcoholic steatohepatitis with fibrosis
by: Leyla Yahaghi, et al.
Published: (2019-12-01)

Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
by: Gang Xu, et al.
Published: (2021-04-01)

Need for liver biopsy in pediatric nonalcoholic steatohepatitis diagnosis regardless of improvement in liver damage through weight loss
by: Toshihiko Kakiuchi, et al.
Published: (2022-03-01)

Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis
by: Xiwei Yuan, et al.
Published: (2023-07-01)

Dietary and genetic disruption of hepatic methionine metabolism induce acid sphingomyelinase to promote steatohepatitis
by: Cristina Alarcón-Vila, et al.
Published: (2023-02-01)

Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity
by: Joseph L. Jilek, et al.
Published: (2021-12-01)

Anti-CD122 antibody restores specific CD8+ T cell response in nonalcoholic steatohepatitis and prevents hepatocellular carcinoma growth
by: Stéphanie Lacotte, et al.
Published: (2023-12-01)

The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis
by: Hui Xiang, et al.
Published: (2022-02-01)

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis
by: Yuki Tsuji, et al.
Published: (2020-06-01)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in MiceSummary
by: Sadatsugu Sakane, et al.
Published: (2021-01-01)

Artificial intelligence and deep learning: New tools for histopathological diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
by: Yoshihisa Takahashi, et al.
Published: (2023-01-01)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
by: Hannah K. Drescher, et al.
Published: (2019-08-01)

The Effect of Diet and Exercise on Improvement of Quality of Life in Patients with Nonalcoholic Steatohepatitis
by: Hossein Nikroo, et al.
Published: (2014-12-01)

Berberine alleviates hepatic inflammation of nonalcoholic steatohepatitis mice by inhibiting oxidative stress and endoplasmic reticulum stress
by: Li Ruikai, Wang Peng, Li Yuqi, Wei Xiuqing
Published: (2024-01-01)